276 results on '"Gronemeyer, Hinrich"'
Search Results
2. Apoptotic cell death in disease—Current understanding of the NCCD 2023
3. Supplementary Table 1 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
4. Data from Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
5. Supplementary Figure 1 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
6. Data from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
7. Supplementary Figure 4 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
8. Supplementary Figure 3 from Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
9. Supplementary Figure 5 from Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
10. Supplementary Figure 1A-D from Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
11. Supplementary Figure 2 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
12. Supplementary Table 1, Figure Legends 1-5 from Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
13. Supplementary Figure 4 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
14. Supplementary Methods from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
15. Supplementary Figure 5 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
16. Supplementary Table 1 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
17. Supplementary Figure 1 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
18. Supplementary Figure 3 from Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
19. Supplementary Figure 5 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
20. Supplementary Figure 2 from Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
21. Data from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
22. Supplementary Figure 2 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
23. Supplementary Figure 5 from Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
24. Supplementary Figure 3 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
25. Supplementary Figure 1A-D from Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
26. Supplementary Figure 2 from Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
27. Supplementary Table 4 from Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
28. Supplementary Methods from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
29. Data from Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
30. Supplementary Figure 3 from Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008
31. Supplementary Table 1, Figure Legends 1-5 from Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
32. Supplementary Figure 1E-J from Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
33. Supplementary Table 4 from Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
34. Supplementary Figure 1E-J from Transformation-Dependent Silencing of Tumor-Selective Apoptosis-Inducing TRAIL by DNA Hypermethylation Is Antagonized by Decitabine
35. Supplementary Figure 4 from Multivalent DR5 Peptides Activate the TRAIL Death Pathway and Exert Tumoricidal Activity
36. Data from Multivalent DR5 Peptides Activate the TRAIL Death Pathway and Exert Tumoricidal Activity
37. Supplementary Figure 2 from Multivalent DR5 Peptides Activate the TRAIL Death Pathway and Exert Tumoricidal Activity
38. Data from Multivalent DR5 Peptides Activate the TRAIL Death Pathway and Exert Tumoricidal Activity
39. Supplementary Figure 5 from Multivalent DR5 Peptides Activate the TRAIL Death Pathway and Exert Tumoricidal Activity
40. Supplementary Figure 1 from Multivalent DR5 Peptides Activate the TRAIL Death Pathway and Exert Tumoricidal Activity
41. Supplementary Figure Legends 1-5 from Multivalent DR5 Peptides Activate the TRAIL Death Pathway and Exert Tumoricidal Activity
42. Synergistic activation of RARβ and RARγ nuclear receptors restores cell specialization during stem cell differentiation by hijacking RARα-controlled programs
43. Faculty Opinions recommendation of Post-gastrulation synthetic embryos generated ex utero from mouse naive ESCs.
44. Faculty Opinions recommendation of Deep Visual Proteomics defines single-cell identity and heterogeneity.
45. Synergistic activation of RARb and RARg nuclear receptors restores cell specialization during stem cell differentiation by hijacking RARa-controlled programs
46. Faculty Opinions recommendation of Signature-scoring methods developed for bulk samples are not adequate for cancer single-cell RNA sequencing data.
47. NGS-QC Generator: A Quality Control System for ChIP-Seq and Related Deep Sequencing-Generated Datasets
48. Faculty Opinions recommendation of Spatial genomics enables multi-modal study of clonal heterogeneity in tissues.
49. Faculty Opinions recommendation of Decoding gene regulation in the fly brain.
50. Complexity against current cancer research: Are we on the wrong track?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.